CONSENT AND AGREEMENT PURSUANT TO NOTE AND WARRANT PURCHASE AGREEMENTConsent and Agreement Pursuant to Note and Warrant Purchase Agreement • March 9th, 2022 • CareView Communications Inc • Radio & tv broadcasting & communications equipment • Delaware
Contract Type FiledMarch 9th, 2022 Company Industry JurisdictionThis CONSENT AND AGREEMENT PURSUANT TO NOTE AND WARRANT PURCHASE AGREEMENT, dated as of March 8, 2022 (this “Consent Agreement”), is made by and among CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (the “Company”), the HealthCor Parties (as defined below), and such additional Existing Investors (as defined below) as, together with the HealthCor Parties (collectively, the “Majority Investors”), are holders of at least a majority of the shares of Common Stock issued or issuable (on an as converted basis) upon conversion of the Notes and Warrants.
CONSENT AND AGREEMENT REGARDING NOTE EXTENSIONSConsent and Agreement Regarding Note • March 9th, 2022 • CareView Communications Inc • Radio & tv broadcasting & communications equipment • New York
Contract Type FiledMarch 9th, 2022 Company Industry JurisdictionThis CONSENT AND AGREEMENT REGARDING NOTE EXTENSIONS (this “Consent Agreement”), dated as of March 8, 2022, by and among CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (“Holdings”), CAREVIEW COMMUNICATIONS, INC., a Texas corporation and a wholly owned subsidiary of Holdings (the “Borrower”), CAREVIEW OPERATIONS, L.L.C., a Texas limited liability company and a wholly owned subsidiary of the Borrower (the “Subsidiary Guarantor”), and PDL INVESTMENT HOLDINGS, LLC, a Delaware limited liability company (as assignee of PDL BioPharma, Inc.), in its capacity as lender under the Credit Agreement defined below (in such capacity, the “Lender”) and in its capacity as agent (in such capacity, the “Agent”) under the Credit Agreement.